home
Bringing New Horizons to Therapy
EDAP TMS in the news
Check the comprehensive list in Media coverage section.
"FDA trials are underway for a new, minimally invasive treatment to fight prostate cancer "
on Fox News TV - October 21, 2008
Ongoing data show HIFU's promise in low-risk prostate cancer
Publised on September 1st 2008
Carry Robertson, the main ENLIGHT FDA clinical study talks about Ablatherm® HIFU clinical results and qualifies Ablatherm® HIFU as "the best minimally-invasive treatment [...] for low grade prostate cancer".
Ablatherm® HIFU press articles in Italian
Published on March 2008
A wide variety of press articles on Ablatherm® HIFU published in various Italian papers in March 2008 at the occasion of the annual European Association of Urology in Milan.
